Abstract
TRH analogues have a longer half-life than does TRH and enhanced neuropharmacological actions. In motorneurone disease (MND), no benefit was reported with MK771 and DN1417. Focal, transient, and slight improvements in weakness and spasticity were described with CG3509. A controlled trial with a single intravenous dose of RX 77368 showed improvements in dysarthria, tongue movements, respiration, swallowing, and spasticity lasting up to 72 hours. Changes in muscle force were of no functional significance. There was an acute 25-30% increase in mean corrected fiber density and in mean macro-EMG parameters in biceps, but no change in amplitude or area of single macro-EMG motor units followed during the 2-hour infusions. An acute, direct or indirect, central effect of RX77368 on recruitment order or on activation threshold of pathological motor units is suggested. In a subacute open trial with repeated intravenous infusions of RX77368 (median 2 weeks), improvement in bulbar function in 8 of 12 responders, cramps (5 of 9), and spasticity (5 of 8) were maintained for medians of 18, 14, and 7 days, respectively. Side effects were prominent with doses above 0.2 mg/kg. Disease progression has not been halted with any analogue, but whether...Continue Reading
References
Feb 1, 1978·Endocrinology·W H DillmannJ H Oppenheimer
Feb 1, 1985·Neuropharmacology·S M Simasko, A Horita
Aug 14, 1986·Biochemical and Biophysical Research Communications·E F HawkinsW K Engel
Feb 1, 1986·Neurology·H MitsumotoJ Leatherman
Sep 1, 1986·Journal of Medicinal Chemistry·T SzirtesL Szporny
Apr 1, 1987·Neurology·T L MunsatI M Jackson
Apr 1, 1987·Neurology·R J HawleyP A Hanson
Oct 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·R J GuiloffS L Lightman
Dec 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·R J GuiloffS L Lightman
May 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·R J GuiloffH Rogers
Sep 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·H Modarres-SadeghiR J Guiloff
Sep 1, 1985·Annals of Neurology·P J Delwaide, J Schoenen
Dec 9, 1985·Brain Research·B V ZlokovićL Rakić
Jul 9, 1983·Lancet·W K EngelJ T Nicoloff
Jul 1, 1983·Electroencephalography and Clinical Neurophysiology·S Nandedkar, E Stålberg
Jan 1, 1983·Endocrinology·M C TononH Vaudry
Jun 15, 1983·Experientia·T Mitsuma, T Nogimori
May 1, 1981·Neuropharmacology·D BrewsterG Metcalf
Sep 1, 1981·Regulatory Peptides·G MetcalfM E Havler
Jun 1, 1980·Journal of Neurology, Neurosurgery, and Psychiatry·E Stålberg
Jun 1, 1981·Anaesthesia·R J Knight
Citations
May 3, 1990·European Journal of Pharmacology·S VonhofV M Labroo
Jan 30, 2002·Pediatric Neurology·Michael J Kubek, Bhuwan P Garg
Jul 16, 1994·BMJ : British Medical Journal·R W OrrellR J Guiloff
Nov 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·H Modarres-Sadeghi, R J Guiloff
Sep 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·D J EcklandR J Guiloff
Feb 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·A Goonetilleke, R J Guiloff
Jan 1, 1991·Mayo Clinic Proceedings·D B Williams, A J Windebank
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Akihiko UrayamaRyohei Kimura
Dec 27, 1994·European Journal of Pharmacology·S B Deshpande, J E Warnick
Apr 20, 2012·The Cochrane Database of Systematic Reviews·Renske I WadmanAlexander F J E Vrancken
Jul 13, 2000·Upsala Journal of Medical Sciences·L O KoskinenJ Svedberg
Nov 1, 1995·Endocrine Research·T MondenM Mori
Dec 16, 1998·Brain Research·M J KubekA J Domb